1- Tong EM, Nissenson AR. Erythropoietin and anemia. Semin Nephrol 2001 ;21:190-203.
2- Bartel LL, Hussey JL, Shrago E. Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy. Am J Clin Nutr 1981;34:1314-20.
3- Battistella PA, Angleini C, Vergani L, Bertoli M, Lorenzi S. Carnitine deficiency induced during haemodialysis. Lancet 1978; 1:939.
4- Guarnieri G, Toigo G, Crapesi L, et al Carnitine metabolism in chronic renal failure. Kidney Int Suppl 1987;22:S116-27.
5-
Albertazz
i A, Capelli P, Di Paolo B, Pola P, Tondi P, Vaccario O. Endocrine-metabolic effects of 1-camitine in patients on regular dialysis treatment. Proc Eur Dial
Transplant Assoc 1983;19:302-307.
6- Vacha GM, Giorcelli G, Siliprandi N, Corsi M. Favorable effects of L-camitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-
cholesterol. Am J Clin Nutr 1983;38:532-540.
7- Bellinghieri G, Savica V, Mallamace A, et al Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 1983;38:523-31.
8- Labonia WD, Morelli OH Jr, Gimenez MI, Freuler PV,
Morelli OH. Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney
Int 1987;32:754-9.
9- Labonia WD. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am
J Kidney Dis 1995;26:757-64.
10- Guarnieri G, Toigo G, Crapesi L, et all. Metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis. Contrib
Nephrol 1988;65:1-23.
11- Gloggler A, Bulla M, Furst P. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children. Kidney Int Suppl 1989;27:S256-8.
12- Golper TA, Wolfson M, Ahmad S, et al. Multicenter
trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.
Kidney Int 1990;38:904-11.
13- Berard E, Iordache A. Effect of low doses of L-carnitine on the response to recombinant human erythropoietin in hemodialyzed children: About two
cases. Nephron 1992;62:368-9.
14- Lilien MR, Duran M, Quak JM, Frankhuisen JJ, Schroder CH. Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis. Pediatr Nephrol 2000; 15 :1 7-20.
15- Boulat O, Janin B, Francioli P, Bachmann C. Plasma
carnitines: reference values in an ambulatory population. Eur J Clin Chem Clin Biochem 1993:31:585-9.
16- Cederblad G, Harper P, Lindgren K. Spectrophotometry of carnitine in biological fluids and tissue with a cobas bio centrifugal analyzer. Clin Chem 1986;32:342-6.
17- Bohmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent haemodialysis for renal
failure Lancet. 1978;1:126-8.
18- Gloggler A, Bulla M, Puchstein C, Gulotta F, Furst P.
Plasma and muscle carnitine in healthy and hemodialyzed children. Child Nephrol Urol 1988-89;9:277-82.
19- Zachwieja J, Duran M, Joles JA, et al. Amino acid and carnitine supplementation in haemodialysed
children. Pediatr Nephrol 1994;8:739-43.
20- Warady BA, Borum P, Stall C, Millspaugh J,
Taggart E, Lum G. Carnitine status of pediatric patients on continuous ambulatory peritoneal
dialysis. Am J Nephrol 1990;10:109-14.
21- Murakami
R
, Momota T, et al. Serum carnitine and
nutritional status in children treated with continuous ambulatory peritoneal dialysis. J
Pediatr Gastroenterol Nutr 1990;11:371-4.
22- Constantin-Teodosiu D, Kirby DP, Short AH,
Burden RP, Morgan AG, Greenhaff PL. Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients. Kidney Int
1996;49:158-62.
23- Pliakogiannis T, Chatzidimitriou C, Evangeliou A, Bohles HJ, Kalaitzidis K. Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal
dialysis. Perit Dial Int Suppl 1993;13:S440-3.
24- Kavadias D, Fourtounas C, Tsouchnikas J, Barboutis K. L-carnitine and erythropoietin requirements in hemodialysis patients. Am J
Kidney Dis 1996,28:156
25- Boran M, Dalva I, Gonenc F, Cetin S. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease. Nephron
1996;73:314-5.
26- Kletzmayr J, Mayer G, Legenstein E, et al. Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int Suppl
1999;69:S93-106.
27- Ahmad S, Bras EP, Hoppel C, et al. Role of L-
carnitine in treating renal dialysis patients. Dial
Transplant 1994;23:177-81.
28- Berard E, Barrillon D, Iordache A, Bayle J, Cassuto-Viguier E. Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients. Nephron 1994;68:145.
29- Matsumura M, Hatakeyama S, Koni I, Mabuchi H, Muramoto H. Correlation between serum
46
carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron 1996;72:574-8.
30- Arduini A, Rossi M, Mancinelli G, et al. Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability.
Life Sci 1990;47:2395-400.
31- Feinfeld DA, Kurian P, Cheng JT, et al. Effect of oral L-carnitine on serum myoglobin in hemodialysis patients. Ren Fail 1996;18:91-6.
32- Kooistra MP, Struyvenberg A, Van Es A. The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels.
Nephron 1991;57:127-8.
Thank you for copying data from http://www.arastirmax.com
